CVRx
Pre-clinicalCVRx offers a heart failure therapy option with Barostim™, the world’s first neuromodulation device for heart failure management. Learn more now!
Founded
2001
Focus
CardiovascularMedical Devices
About
CVRx offers a heart failure therapy option with Barostim™, the world’s first neuromodulation device for heart failure management. Learn more now!
Funding History
6Total raised: $313M
IPO$108MUndisclosedSep 23, 2021
Series E$40MUndisclosedJun 15, 2015
Series D$60MUndisclosedAug 15, 2010
Series C$50MUndisclosedMar 15, 2007
Company Info
TypePrivate
Founded2001
LocationMinneapolis, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile